Circ-ZNF609 was found to be exceptionally up-regulated and carried out diagnostic biomarker roles in breast cancer, renal cancer, colorectal carcinoma, rhabdomyosarcoma, nasopharyngeal carcinoma, gastric cancer and lung adenocarcinoma [18–25]. This evidence concerns the gene ZNF609 and renal carcinoma.